English  |  正體中文  |  简体中文  |  Items with full text/Total items : 1657/1756
Visitors : 3812587      Online Users : 152
RC Version 5.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Adv. Search
LoginUploadHelpAboutAdminister

Please use this identifier to cite or link to this item: http://140.112.115.32:8080/ir/handle/987654321/2773

Title: Hinokitiol negatively regulates immune responses through cell cycle arrest in concanavalin A-activated lymphocytes
Authors: Chi-Li Chung;Kam-Wing Leung;Wan-Jung Lu;Ting-Lin Yen;Chia-Fu He;Joen-Rong Sheu;Kuan-Hung Lin;Li-Ming Lien
Contributors: 視光學系
Date: 2015-08-01
Issue Date: 2025-08-01 15:07:03 (UTC+8)
Abstract: Autoimmune diseases are a group of chronic inflammatory diseases that arise from inappropriate inflammatory responses. Hinokitiol, isolated from the wood of Chamaecyparis taiwanensis, engages in multiple biological activities. Although hinokitiol has been reported to inhibit inflammation, its immunological regulation in lymphocytes remains incomplete. Thus, we determined the effects of hinokitiol on concanavalin A- (ConA-) stimulated T lymphocytes from the spleens of mice. In the present study, the MTT assay revealed that hinokitiol (1?5??M) alone did not affect cell viability of lymphocytes, but at the concentration of 5 ?M it could reduce ConA-stimulated T lymphocyte proliferation. Moreover, propidium iodide (PI) staining revealed that hinokitiol arrested cell cycle of T lymphocytes at the G0/G1 phase. Hinokitiol also reduced interferon gamma (IFN-?) secretion from ConA-activated T lymphocytes, as detected by an ELISA assay. In addition, hinokitiol also downregulated cyclin D3, E2F1, and Cdk4 expression and upregulated p21 expression. These results revealed that hinokitiol may regulate immune responses. In conclusion, we for the first time demonstrated that hinokitiol upregulates p21 expression and attenuates IFN-? secretion in ConA-stimulated T lymphocytes, thereby arresting cell cycle at the G0/G1 phase. In addition, our findings also indicated that hinokitiol may provide benefits to treating patients with autoimmune diseases.
Relation: Evidence-Based Complementary and Alternative Medicine, 2015(1), 595824. https://doi.org/10.1155/2015/595824
Appears in Collections:[視光學系] 期刊論文

Files in This Item:

File SizeFormat
index.html0KbHTML10View/Open


All items in MMUIR are protected by copyright, with all rights reserved.

 


DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback